Clinical Trial Update: Effect of Hi-OxSR for the Treatment of Post COVID Condition [NA]

View source ↗

Summary

A clinical trial is investigating Hi-OxSR for post-COVID-19 condition and is currently recruiting. The study is sponsored by University Health Network, Toronto.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-acute Sequelae of Sars-cov-2 Infection

Drugs mentioned

• Hi-OxSR

Snippet

Sponsor: University Health Network, Toronto | Conditions: Long COVID, Post COVID-19 Condition | NA | Status: RECRUITING